A common hematopoietic precursor to innate lymphoid cells
先天淋巴细胞的常见造血前体
基本信息
- 批准号:9110098
- 负责人:
- 金额:$ 38.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAllergic DiseaseAllergic inflammationAnimalsAutomobile DrivingBacterial InfectionsBone MarrowCandidate Disease GeneCategoriesCell LineageCellsCitrobacter rodentiumClassificationCommunicable DiseasesComparative StudyConfusionDefectDendritic CellsDeveloping CountriesDevelopmentDiseaseEnteralEpithelial CellsFetal LiverGeneticGenetic ModelsHealthHematopoieticHost DefenseHypersensitivityImmuneImmune systemImmunocompetentImmunodeficient MouseIn VitroInfectionInternal Ribosome Entry SiteKnockout MiceKnowledgeLaboratoriesLymphocyteLymphocyte SubsetLymphoidLymphoid CellLymphoid TissueMapsMissionModelingMolecularMolecular ProfilingMusMyelogenousNatural Killer CellsNippostrongylusOrgan Culture TechniquesParasitic infectionPhysiologyPlayPopulationPublic HealthReporterResearchRoleStagingStudy modelsSystemTestingUnited States National Institutes of HealthVirus DiseasesWorkZNF145 geneadaptive immunitycytokinegenetic approachhuman diseasein vivoinhibitor/antagonistinnovationinsightmicrobiotamouse modelnovelnovel strategiespathogenpreventprogenitorresponsetissue repairtooltranscription factor
项目摘要
DESCRIPTION (provided by applicant): Innate lymphocytes (ILC) are novel populations of lymphocytes that reside at mucosal barriers and play critical functions in clearing infections, inducing allergic inflammation or directing tissue repair. Different lineages of ILCs are specialized in the secretion of polarized sets of cytokines that orchestrate rapid protective responses against various categories of pathogens. Thus, their study is relevant to a broad range of diseases across western and third-world countries. The development and the lineage relationships between different populations of ILCs, including ILC2s, ILC22s, lymphoid tissue inducers (LTis) and NK cells, are poorly understood and there is considerable confusion regarding the identity and function of these ILCs in the healthy state and in the context of disease. In the absence of genetic models alowing specific manipulation of these lineages in vivo, studies have been largely limited to immunodeficient mice lacking an adaptive immune system and it is unclear whether their conclusions will apply to normal animals. This project builds on preliminary studies of PLZF-IRES-GFPCre reporter mice produced in our laboratory showing that the transcription factor PLZF, previously identified as the signature of the innate-like NKT cell lineage, is also expressed at high levels during the development of ILC2s and ILC22s but not NK or LTi cells. The central hypothesis is that PLZF marks a common bone marrow precursor to ILC2s and ILC22s and is essential for normal development and function. The objective of this application is to use PLZF-IRES-GFPCre mice to identify the bone marrow precursors of ILCs, characterize their molecular signature and genetically manipulate ILCs in vivo in order to define their function in well-established models of enteric infections. The specifc aims are 1) to identify the PLZF-expressing bone marrow precursor of ILC lineages, 2) to characterize its molecular signature; 3) to create ILC-defective mouse models for studies of enteric infections. The proposal is innovative and significant because it identifies a novel bone marrow precursor and a novel transcription factor for ILCs and because it will produce models for studies of ILCs in the context of infections in immunocompetent animals.
描述(由申请人提供):先天淋巴细胞(ILC)是存在于粘膜屏障的新型淋巴细胞种群,并在清除感染,引起过敏性炎症或指导组织修复方面起着关键功能。 ILC的不同谱系专门用于分泌一组极化的细胞因子,这些细胞因子策划了针对各种病原体的快速保护反应。因此,他们的研究与西方和第三世界国家的各种疾病有关。知识渊博,包括ILC2,ILC22S,淋巴组织诱导剂(LTI)和NK细胞在内的不同种群的ILC种群之间的发展和谱系关系知之甚少,并且在健康状态和疾病的背景下,这些ILC的身份和功能都存在很大的混淆。在没有遗传模型的情况下,在体内对这些谱系的特异性操纵的情况下,研究在很大程度上仅限于缺乏适应性免疫系统的免疫缺陷小鼠,目前尚不清楚它们的结论是否适用于正常动物。该项目的基于我们实验室中产生的PLZF-IRES-GFPCRE记者小鼠的初步研究,表明,以前被确定为先天天生的NKT细胞谱系的转录因子PLZF在ILC2S和ILC22S和ILC22S的开发过程中也以高水平表达,但不是NK或NK或LTI细胞。中心假设是PLZF标志着ILC2S和ILC22S的常见骨髓前体,对于正常发育和功能至关重要。该应用的目的是使用PLZF-IRES-GFPCRE小鼠鉴定ILC的骨髓前体,以体内表征其分子特征,并在体内遗传操纵ILC,以定义其在熟悉的肠道感染模型中的功能。指定的目的是1)识别ILC谱系表达PLZF的骨髓前体,2)表征其分子特征; 3)创建ILC缺陷的小鼠模型来研究肠道感染。该提案具有创新性和意义,因为它可以识别出新型的骨髓前体和ILC的新型转录因子,并且因为它将在免疫能力动物的感染中生成用于研究ILC的模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALBERT S. BENDELAC其他文献
ALBERT S. BENDELAC的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALBERT S. BENDELAC', 18)}}的其他基金
Transcriptional Regulation of Innate-Like T Cells
先天样 T 细胞的转录调控
- 批准号:
10441712 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别:
Development of Intestinal Polyreactive IgA B Cells
肠道多反应性 IgA B 细胞的发育
- 批准号:
10543053 - 财政年份:2019
- 资助金额:
$ 38.39万 - 项目类别:
Development of Intestinal Polyreactive IgA B Cells
肠道多反应性 IgA B 细胞的发育
- 批准号:
10321246 - 财政年份:2019
- 资助金额:
$ 38.39万 - 项目类别:
Development of Intestinal Polyreactive IgA B Cells
肠道多反应性 IgA B 细胞的发育
- 批准号:
10078246 - 财政年份:2019
- 资助金额:
$ 38.39万 - 项目类别:
A common hematopoietic precursor to innate lymphoid cells
先天淋巴细胞的常见造血前体
- 批准号:
9312731 - 财政年份:2014
- 资助金额:
$ 38.39万 - 项目类别:
A common hematopoietic precursor to innate lymphoid cells
先天淋巴细胞的常见造血前体
- 批准号:
8612741 - 财政年份:2014
- 资助金额:
$ 38.39万 - 项目类别:
Allergic inflammation in genetic models of lung ILC2 deficiency
肺 ILC2 缺陷遗传模型中的过敏性炎症
- 批准号:
8576628 - 财政年份:2013
- 资助金额:
$ 38.39万 - 项目类别:
Allergic inflammation in genetic models of lung ILC2 deficiency
肺 ILC2 缺陷遗传模型中的过敏性炎症
- 批准号:
8847790 - 财政年份:2013
- 资助金额:
$ 38.39万 - 项目类别:
Control of lymphoid effector programs by the E3 ligase cullin 3
E3 连接酶 cullin 3 控制淋巴效应程序
- 批准号:
8651505 - 财政年份:2013
- 资助金额:
$ 38.39万 - 项目类别:
相似国自然基金
基于社会生态理论的儿童过敏性疾病及其健康影响的多维风险因素识别、动态预警及健康管理策略研究
- 批准号:72374059
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
空气污染与食物过敏原早期暴露对儿童第二波过敏性疾病的影响研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
钙结合蛋白S100A4通过RAGE-PPARg调控肥大细胞代谢及其对过敏性疾病的作用
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
钙结合蛋白S100A4通过RAGE-PPARg调控肥大细胞代谢及其对过敏性疾病的作用
- 批准号:82260324
- 批准年份:2022
- 资助金额:33.00 万元
- 项目类别:地区科学基金项目
治疗过敏性疾病相关激酶靶点群的确定及先导化合物发现
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Early Life Pulmonary Infection, Microbiome and Trained Innate Immunity
生命早期肺部感染、微生物组和经过训练的先天免疫
- 批准号:
10677304 - 财政年份:2023
- 资助金额:
$ 38.39万 - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
$ 38.39万 - 项目类别:
Metformin IN Asthma for overweight and obese individuals (MINA)
二甲双胍用于超重和肥胖人群的哮喘治疗 (MINA)
- 批准号:
10740950 - 财政年份:2023
- 资助金额:
$ 38.39万 - 项目类别:
Defining the role of IL-18 in atopic dermatitis
定义 IL-18 在特应性皮炎中的作用
- 批准号:
10681016 - 财政年份:2023
- 资助金额:
$ 38.39万 - 项目类别:
Impact of Maternal Arsenic Exposure on Offspring's Epigenetic Reprogramming of Allergic Airway Disease
母亲砷暴露对后代过敏性气道疾病表观遗传重编程的影响
- 批准号:
10733607 - 财政年份:2023
- 资助金额:
$ 38.39万 - 项目类别: